Discover Aragen’s latest innovations in biologics development and manufacturing. In this exclusive on-demand session, Jamie Cascio, AVP – Biologics at Aragen, presents a scientific update on our capabilities and introduces our newly commissioned, state-of-the-art biologics manufacturing facility in Bengaluru, India.
Bioreactor capacity from 50L to 2000L, with expansion plans up to 5000L
A fully integrated Drug Product (DP) fill-finish line
A dedicated Antibody-Drug Conjugation (ADC) suite
This facility is set to redefine bioproduction standards in India, offering end-to-end biologics development and manufacturing solutions.
Jamie Cascio, PhD, PMP®
AVP, Biologics, Aragen
